US Stock MarketDetailed Quotes

SLRX Salarius Pharmaceuticals

Watchlist
  • 1.6700
  • +0.0065+0.39%
Close Dec 27 16:00 ET
  • 1.5800
  • -0.0900-5.39%
Post 20:01 ET
2.41MMarket Cap-0.32P/E (TTM)

Salarius Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-60.25%1.01M
-63.05%1.47M
-67.32%1.77M
-43.87%12.89M
-85.02%970.7K
-54.96%2.53M
-16.53%3.97M
-11.39%5.42M
79.31%22.98M
181.08%6.48M
Selling and administrative expenses
-41.89%869.24K
-22.63%1.25M
-9.82%1.53M
-19.85%5.72M
-49.18%910.75K
-18.35%1.5M
-11.81%1.62M
1.03%1.7M
16.93%7.14M
23.67%1.79M
-General and administrative expense
-41.89%869.24K
-22.63%1.25M
-9.82%1.53M
-19.85%5.72M
-49.18%910.75K
-18.35%1.5M
-11.81%1.62M
1.03%1.7M
16.93%7.14M
23.67%1.79M
Research and development costs
-86.76%137.23K
-90.88%214.45K
-93.48%243K
-54.70%7.17M
-98.72%59.95K
-72.66%1.04M
-19.50%2.35M
-16.08%3.73M
85.26%15.84M
73.82%4.69M
Operating profit
60.25%-1.01M
63.05%-1.47M
67.32%-1.77M
43.87%-12.89M
85.02%-970.7K
54.96%-2.53M
16.53%-3.97M
11.39%-5.42M
-79.31%-22.98M
-56.29%-6.48M
Net non-operating interest income expense
-61.56%34.35K
-54.21%43.08K
-29.50%56.33K
61.04%352.25K
-3.88%88.91K
13.69%89.37K
137.42%94.09K
898.13%79.89K
218.73K
92.49K
Non-operating interest income
-61.56%34.35K
----
-29.50%56.33K
61.04%352.25K
-3.88%88.91K
13.69%89.37K
----
898.13%79.89K
--218.73K
--92.49K
Total other finance cost
----
54.21%-43.08K
----
----
----
----
-137.42%-94.09K
----
----
----
Other net income (expense)
-19,905.01%-8.85M
-63.40%14.45K
Gain on sale of security
----
----
----
----
----
----
----
----
-67.66%14.45K
----
Special income (charges)
----
----
----
--0
----
----
----
----
---8.87M
--0
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--8.87M
--0
Income before tax
60.20%-972.12K
63.26%-1.42M
67.88%-1.72M
60.32%-12.54M
86.16%-881.8K
83.05%-2.44M
17.82%-3.88M
12.58%-5.34M
-147.55%-31.61M
-55.20%-6.37M
Income tax
Net income
60.20%-972.12K
63.26%-1.42M
67.88%-1.72M
60.32%-12.54M
86.16%-881.8K
83.05%-2.44M
17.82%-3.88M
12.58%-5.34M
-147.55%-31.61M
-55.20%-6.37M
Net income continuous Operations
60.20%-972.12K
63.26%-1.42M
67.88%-1.72M
60.32%-12.54M
86.16%-881.8K
83.05%-2.44M
17.82%-3.88M
12.58%-5.34M
-147.55%-31.61M
-55.20%-6.37M
Minority interest income
Net income attributable to the parent company
60.20%-972.12K
63.26%-1.42M
67.88%-1.72M
60.32%-12.54M
86.16%-881.8K
83.05%-2.44M
17.82%-3.88M
12.58%-5.34M
-147.55%-31.61M
-55.20%-6.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
60.20%-972.12K
63.26%-1.42M
67.88%-1.72M
60.32%-12.54M
86.16%-881.8K
83.05%-2.44M
17.82%-3.88M
12.58%-5.34M
-147.55%-31.61M
-55.20%-6.37M
Basic earnings per share
85.41%-0.76
79.30%-2.37
81.61%-3.28
74.19%-30.72
99.95%-0.01
89.84%-5.21
34.94%-11.45
32.42%-17.84
-92.75%-119.04
-22.22%-22
Diluted earnings per share
85.41%-0.76
79.30%-2.37
81.61%-3.28
74.19%-30.72
99.95%-0.01
89.84%-5.21
34.94%-11.45
32.42%-17.84
-92.75%-119.04
-22.22%-22
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -60.25%1.01M-63.05%1.47M-67.32%1.77M-43.87%12.89M-85.02%970.7K-54.96%2.53M-16.53%3.97M-11.39%5.42M79.31%22.98M181.08%6.48M
Selling and administrative expenses -41.89%869.24K-22.63%1.25M-9.82%1.53M-19.85%5.72M-49.18%910.75K-18.35%1.5M-11.81%1.62M1.03%1.7M16.93%7.14M23.67%1.79M
-General and administrative expense -41.89%869.24K-22.63%1.25M-9.82%1.53M-19.85%5.72M-49.18%910.75K-18.35%1.5M-11.81%1.62M1.03%1.7M16.93%7.14M23.67%1.79M
Research and development costs -86.76%137.23K-90.88%214.45K-93.48%243K-54.70%7.17M-98.72%59.95K-72.66%1.04M-19.50%2.35M-16.08%3.73M85.26%15.84M73.82%4.69M
Operating profit 60.25%-1.01M63.05%-1.47M67.32%-1.77M43.87%-12.89M85.02%-970.7K54.96%-2.53M16.53%-3.97M11.39%-5.42M-79.31%-22.98M-56.29%-6.48M
Net non-operating interest income expense -61.56%34.35K-54.21%43.08K-29.50%56.33K61.04%352.25K-3.88%88.91K13.69%89.37K137.42%94.09K898.13%79.89K218.73K92.49K
Non-operating interest income -61.56%34.35K-----29.50%56.33K61.04%352.25K-3.88%88.91K13.69%89.37K----898.13%79.89K--218.73K--92.49K
Total other finance cost ----54.21%-43.08K-----------------137.42%-94.09K------------
Other net income (expense) -19,905.01%-8.85M-63.40%14.45K
Gain on sale of security ---------------------------------67.66%14.45K----
Special income (charges) --------------0-------------------8.87M--0
-Less:Impairment of capital assets --------------0------------------8.87M--0
Income before tax 60.20%-972.12K63.26%-1.42M67.88%-1.72M60.32%-12.54M86.16%-881.8K83.05%-2.44M17.82%-3.88M12.58%-5.34M-147.55%-31.61M-55.20%-6.37M
Income tax
Net income 60.20%-972.12K63.26%-1.42M67.88%-1.72M60.32%-12.54M86.16%-881.8K83.05%-2.44M17.82%-3.88M12.58%-5.34M-147.55%-31.61M-55.20%-6.37M
Net income continuous Operations 60.20%-972.12K63.26%-1.42M67.88%-1.72M60.32%-12.54M86.16%-881.8K83.05%-2.44M17.82%-3.88M12.58%-5.34M-147.55%-31.61M-55.20%-6.37M
Minority interest income
Net income attributable to the parent company 60.20%-972.12K63.26%-1.42M67.88%-1.72M60.32%-12.54M86.16%-881.8K83.05%-2.44M17.82%-3.88M12.58%-5.34M-147.55%-31.61M-55.20%-6.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 60.20%-972.12K63.26%-1.42M67.88%-1.72M60.32%-12.54M86.16%-881.8K83.05%-2.44M17.82%-3.88M12.58%-5.34M-147.55%-31.61M-55.20%-6.37M
Basic earnings per share 85.41%-0.7679.30%-2.3781.61%-3.2874.19%-30.7299.95%-0.0189.84%-5.2134.94%-11.4532.42%-17.84-92.75%-119.04-22.22%-22
Diluted earnings per share 85.41%-0.7679.30%-2.3781.61%-3.2874.19%-30.7299.95%-0.0189.84%-5.2134.94%-11.4532.42%-17.84-92.75%-119.04-22.22%-22
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
0.00%
Petroleo Brasileiro SA Petrobras
PBR
-0.13%
Vale SA
VALE
-0.45%
Meta Platforms
META
-0.59%
Adobe
ADBE
-0.82%

Unlock the Full List